The murid herpesvirus 4 (MuHV 4) species encompasses 7 isolates, out of which at least two (MHV-68, MHV-72) became in vitro propagated laboratory strains. Following intranasal inoculation, MuHV 4 induces an acute infectious mononucleosis-like syndrome with elevated levels of peripheral blood leukocytes, shifts in the relative proportion of lymphocytes along with the appearance of atypical mononuclear cells. At least two isolates exhibited spontaneous deletions at the left hand (5´-end) of their genome, resulting in the absence of M1, M2, M3 genes (strain MHV-72) and also of the M4 gene (strain MHV-76). Based on DNA sequence amplifications only, another two isolates (MHV-Šum and MHV-60) were shown to possess similar deletions of varying length. During latency (until 24 months post-infection), the mice infected with any MuHV 4 isolate (except MHV-76) developed lymphoproliferative disorders. The lack of tumor formation in MHV-76 infected mice was associated with persistent virus production at late post-infection intervals. In addition to careful analysis of spontaneously occurring 5´-end genome defects, our knowledge of the function of 5´-end genes relies on the behaviour of mutants with corresponding deletions and/or insertions. While M2 and M3 genes encode immune evasion proteins, M4 codes for a soluble glycopeptide acting as immunomodulator and/or immunostimulator.
Introduction
The history of murine herpesvirus goes back to 1980, when several herpesvirus isolates (designated MHV-60; MHV-68; MHV-72; MHV-76; MHV-78, MHV-ŠUM) were obtained from free-living Clethrionomys and Apodemus rodents captured in different regions of the former Czechoslovakia [1, 2] . All the MHV isolates grew well in cell cultures of mouse, chick, rabbit, hamster, mink, swine, monkey or human origin (especially primary or diploid embryonic cells), indicating that the new herpes virus was not a cytomegalovirus [3] . Later on Efstathiou et al. [4] showed that the genome of MHV-68 had at least
Comparison of pathogenic properties of the murid gammaherpesvirus (MuHV 4) strains: a role for immunomodulatory proteins encoded by the left (5'-)end of the genome 16 ORFs, which are homologous to Epstein Barr virus (EBV) and to Herpesvirus saimiri sequences. Based on these data, the murine herpesvirus strain 68 (MHV-68) was classified into genus Rhadinovirus, subfamily Gammaherpesvirinae. All the above-mentioned isolates, which are serologically highly related [5] , were classified as a single species of Murid herpesvirus 4 (MuHV 4) [6] .
Pathogenesis of the prototype strain MHV-68 in laboratory mice
Pilot studies with the MHV-68 strain showed that, in response to intranasal (i.n.) inoculation into outbred mice, this virus spreads to the lungs and then via the bloodstream it reaches several internal organs such as the spleen, liver, and kidneys [7] . The survivors of acute infection, especially adult and juvenile mice, developed latent (and/or persistent) infection in the same organs. In contrast to herpes simplex viruses (HSV 1 and 2), the absence of neural spread was a striking feature [8] .
Though the MuHV 4 isolates are not strictly lymphotropic, based on their genomic structure, the new isolates were classified as members of the Gammaherpesvirinae subfamily [4] . Using a combination of serology and PCR analysis, Blasdell et al. [9] found that MuHV 4 was endemic in wood mice (Apodemus sylvaticus) but not in two species of voles (Clethrionomys glareolus, Microtus agrestis). More recently, a longitudinal study of MuHV 4 antibody in a mixed ensemble of bank voles (C. glareolus) and wood mice (A. sylvaticus) showed that the latter represent the more frequent reservoir, even when the virus was originally isolated from the former [10] . Studies in Balb/c mice using MHV-68 demonstrated that the lung tissue becomes primarily involved following i.n. inoculation [11] . Splenomegaly occurred in the course of acute infection as well as at late post-infection (p.i.) intervals among healthy survivors, in which B cells were predominant virus carriers [12] . Depletion of T/CD4 lymphocytes prevented splenomegaly, but had no effect on B cell-associated latency [13] . Persistent infection with MHV-68 was established in mouse myeloma B cells (NSO cells) but not in thymoma BW5147 cells [14] . Marques et al. [15] described the frequency of MHV-68 infection in splenic B lymphocytes, in dendritic cells and macrophages at acute as well as latent stages p.i. At early intervals, B cells within the marginal zone of germinal centres accounted for nearly the half of the total number of infected splenocytes.
When the µMT transgenic mice (which do not produce heavy µ-chains, and therefore, do not have mature B cells) were used to establish latency, MHV-68 DNA persisted in the lungs, namely in pulmonary epithelial cells [13] . Using the latter model, the IgM deficient CD21-positive lymphocytes became latent virus carriers at a lower frequency, since macrophages and NK cells formed the main cell population, in which the viral DNA survived. Obviously, in B cell-deficient mice, the B lymphocytes cannot account for latency [16] . When adherent mononuclear cells (AMC) from infected Balb/c mice were T-cell depleted and enriched by means of the anti-macrophage F4/80 monoclonal antibody, this AMC population was shown to contain MHV-68 DNA at late p.i. intervals [17] . Thus, both lymphocytes as well as macrophages may represent the reservoir of latent virus especially in adult animals, which did not undergo acute disease.
The B lymphocytes producing MHV-68 or expressing MHV-68 antigen(s), may be cleared from blood, lymph nodes, spleen and lung alveoli by cytotoxic T/CD8 cells. As a result of virus replication in the lungs, the T/ CD8 cells accumulate in the mediastinal lymph nodes [18, 19] . Mice depleted of T/CD8 cells failed to resolve the pulmonary disease, developed a long lasting viremia and died; this confirms that T/CD8 lymphocytes are essential for virus clearance. However, the cooperation of CD8 lymphocytes with CD4 T cells is still required for long-term protection [20, 21] . MHV-68 infection may also be associated with massive proliferation of those lymphocytes that are not specific for this virus. The level of "bystander-induced" cycling in a population of influenza virus-specific T/CD8 + cells was fourfold lower than was the extent of cell division driven by the specific MHV-68 antigen [22] .
Following i.n. MHV-68 inoculation, viremia occurs due to virus replication in the alveolar epithelium and endothelial cells of alveolar septa at acute p.i. intervals. The productive virus growth within lung epithelium is resolved at 7 to 10 days p.i. During the viremic phase, the mature B cells as well as macrophages become infected. In the course of primary infection, the T/CD8 cells (in cooperation with T/CD4 cells) proliferate to participate in the clearance of infected B lymphocytes expressing MuHV 4 antigens. The kinetics of the T/ CD8 cell response may be different when tested against various proteins expressed during the lytic cycle or those associated with latency. Thus, the cellular immune response shows a complex pattern reflecting the distinct expression of virus-coded polypeptides in antigen presenting cells (APC) and B lymphocytes [23] . The acute infectious mononucleosis (IM) like syndrome shows splenomegaly, an increased number of proliferating B cells and atypical mononuclear cells. Thus, it represents an animal model for EBV infection [24] .
Comparison of biological properties of other MuHV 4 strains
The role for macrophages in the spread of MuHV 4 was first postulated by Mistriková et al. [25] , who claimed that adherent lung and/or peripheral blood mononuclear cells (mainly macrophages) participate in virus dissemination during acute infection with the MHV-72 strain. Plaque assay combined with nested PCR confirmed the hematogenic spread of MHV-72 to the mammary glands of female nu/nu Balb/c mice and its transmission to the offspring via breast milk [26, 27] . In Balb/c mice infected with MHV-72, the number of T/CD8 cells reached maximum by day 11 p.i., and remained elevated till day 30 p.i.. This correlated with increased levels of T/ CD4 cells and elevated numbers of activated B/CD19 lymphocytes and NK cells [28] . The atypical leukocytes, which could be found in the mouse IM-like syndrome following acute MHV-72 infection, were classified as lymphoblasts. The population of peritoneal, alveolar and bone marrow cells occasionally yielded virus for up to eight months p.i., indicating that mononuclear phagocytes could harbour the latent MHV-72 for a considerable period of time and that they occasionally produce infectious virus. Some mice with latent MHV-72 infection showed signs resembling a leukemia-like syndrome with splenomegaly and lymphadenopathy, with an extremely high number of peripheral blood leukocytes and an increased proportion of immature blastic leukocytes [29] . Lymphoproliferative disease and lymphomas were first described in MHV-68 infected mice [30] . We reported tumors histologically verified as lymphomas, non-differentiated lymphoblastomas and/or sarcomas in 10 out of 100 Balb/c mice which had been inoculated i.n. with MHV-72 and then kept for over 2 years [31] . The lymphoid cells present in lymphomas or lymphoblastomas expressed the pan-T/CD45 marker [32] . In addition to lymphomas, neoplasms such as skin tumors (squamous cell carcinoma, hemangioma), were also seen in long term observed animals, including controls. Statistical analysis confirming the relevance of the association between MHV-72 and various tumors in CB17scid/scid mice was reported by Oda et al. [33] . The latter authors, however, did not find viral DNA in the tumors of MHV-72 infected mice. In our hands, infectious virus was recovered by explantation (or co-cultivation) from nearly the half of lymphoma and sarcoma tissues. One sarcoma was used to establish a cell fibroblast cell line, which yielded scattered IF-positive MHV plaques at the 42nd passage (not published). Later on, we referred to the cell line NB-78, derived from a lymphoma, which had developed in a MHV-78 infected Balb/c mouse; this cell line expressed MHV antigen in a small proportion of cells at passages 43-45 [34] . reported that the S11 B-lymphoma derived cell line contains MHV-68 genomes, either linear or episomal [35] . Tarakanova et al. (2005) found abundant positive cells by in situ hybridization with probes specific for vtRNA in the samples from lymphoproliferative lesions of MHV-68 infected Balb/c mice deficient for the b2-microglobulin subunit of MHC [36] . On the other hand, the frequency of vtRNA positive cells was low in lymphomas of the same origin and scarce in the spleen of infected animals.
When athymic nude mice (BALB/c) were injected subcutaneously with MHV-72, the animals died 1 month p.i. showing a high frequency (48%) of atypical lymphoblast-like B cells in the blood, but showing no increase in the number of natural killer (NK) cells. The use of UV-irradiated virus increased mouse survival time (by up to 3 months p.i.). The atypical lymphocytes in the peripheral blood were similar in shape to those seen following infection with the non-irradiated virus. However, nude mice did not develop splenomegaly, probably due to the lack of the T cell subset. These findings suggest that NK cells do not play an important role in immune defences against MuHV 4 infection in nude mice [37] .
BALB/c mice inoculated by i.n. route with the isolate Šumava (MHV-ŠUM) showed increased number of leukocytes and appearance of atypical peripheral blood cells during acute infection. The infiltration of spleen with atypical cells resulted in splenomegaly. In the course of latent infection predominantly non-infectious virus (viral DNA) persisted in lungs, spleen, thymus, bone marrow, mammary glands, peritoneal macrophages and liver. A leukemia-like syndrome associated with strain MHV-ŠUM developed at remote intervals (day 350 to 810 p.i.) in Balb/c mice, showing leukocytosis ranging from 8x10 4 to 5x10 5 cells/ml and as many as 60% atypical lymphocytes in the total peripheral blood cell count [38] .
In Balb/c mice infected i.n. with MHV-78 strain the distribution of infectious virus was followed for up to 180 days. High virus levels (over 100 TCID 50 /ml) were reached in lungs on days 9-28 p.i. and in blood leukocytes on day 7. Similar virus levels were detected in the spleen at remote intervals (days 60-180 p.i.) by means of a co-cultivation technique. The persisting virus was detected in bone marrow, thymus, peritoneal macrophages and mammary glands [39] . Elevated numbers of blood leukocytes and atypical mononuclear cells in blood smears were seen on day 15 p.i. Reactivation of latent MHV-78 was proven by detecting the infectious virus in the culture medium at passages 43-45 only. Summing up, NB-78 is a continuous cell line derived from a tumor which developed in the MHV-78 infected host; it harbors the latent viral genome and rarely produces infectious virus upon spontaneous reactivation [34] .
Following infection with the MHV-60 strain, the lungs again represented the main portal of entry [40] . The pathological features of the acute phase were similar to those elicited by other MuHV 4 isolates, including the prototype MHV-68 virus. Nevertheless, the MHV-60 strain differed from others as follows: (A) The acute phase showed fast dynamics peaking on days 3-5 p.i., never exceeding a total of 10 days (in contrast to the 14-28 day duration of acute viremic phase in the above mentioned isolates). At given intervals, an increased number of leukocytes in peripheral blood had been observed along with the appearance of atypical leukocytes. In addition to lungs, infectious virus could be recovered from spleen, thymus and kidneys, but not from other organs. Acute splenomegaly was prominent in contrast to infection with the MHV-78 strain. (B) Massive splenomegaly was characteristic of the chronic leukemia-like disease. Despite the quick clearance of infectious virus, MHV-60 latency was associated with a high probability of tumor formation (as high as 22%) even when considering the 5% frequency of spontaneous tumors that appeared in non-infected controls kept for the same observation period.
The frequency of tumors and other important data concerning the Balb/c mice infected with various MuHV 4 strains (or isolates) are shown on Table 1 . From this Table it is that clear that the highest frequency of tumor formation was observed with MHV-60, while no tumors developed in MHV-76 infected animals. After i.n. inoculation of MHV-76, the infectious virus spread to lungs, where it replicated to relatively high titers until day 7 p.i. [41] . This agrees with the results of Macrae et al. [42] , who describe the rapid clearance of MHV-76 within lungs. Via blood macrophages small amounts of MHV-76 virus could be disseminated to many organs, since the virus reappeared at remote intervals (from 1 to 27 months p.i.), and unexpectedly persisted in the spleen, liver, bone marrow, lymph nodes, kidneys, thymus as well as in the small intestine, spinal cord and brain. Slightly elevated numbers of leukocytes in peripheral blood were accompanied by atypical leukocytes (ranging from 3 to 13%) at early as well as late (by 5 and 15 months) intervals p.i. Despite this, the MHV-76 infected Balb/c mice developed neither splenomegaly nor showed solid tumors.
The MuHV 4 genome and spontanous deletions at its 5´-end
The MHV-68 DNA has sequences homologous to EBV [4] , KHSV and HVS viruses [43] . [45, 46] . The expression of murine herpesvirus tRNAs is driven by the cellular RNA polymerase III, which is active in any mammalian cell [47] . Though their exact function is still unknown, some workers claim that they might represent analogues to EB early RNA (EBER) molecules encoded by EBV [48] . Recently, it was shown that the small non-coding tRNAs transcribed from the viral genome reveal a segment with silencer function identified as microRNA (miRNA) [49] . This may point at the possible role of MHV-68 tRNA, when expressed in spleen germinal centres during latent infection. In any case, the presence of tRNA is regarded as a hallmark of latent infection [45, 47] . Although the complete sequence of the MHV-68 genome has been determined, our knowledge of the function of individual genes is still limited. Out of a total of 82 genes, only 48 encode proteins with clearly identified function. The MHV ORFs fall into 3 categories: (A) genes common to the gammaherpesvirus subfamily, (B) genes common to the herpesvirus family and (C) unique murine herpesvirus genes (designated M1-M9, M10a,b,c, M11-M14). From the latter, we attempted to define the function of M1-to M4-encoded polypeptides based on a survey of the pathogenic behaviour of spontaneous and artificial mutants lacking various proportions of the 5´-end of the MuHV 4 genome.
Analysis of MHV-76 DNA showed a spontaneous 9,538 bp deletion at the 5´-end resulting in the loss of M1, M2, M3 and M4 genes as well as the ORFs from which the tRNAs are ordinarily transcribed [42] . The deletion in question was confirmed by restriction endonuclease cleavage, by PCR amplification of the genes in question and, finally, by Southern blot hybridization using radiolabeled probes derived from MHV-68 and MHV-76 DNAs. Repeated and independent studies on the pathogenesis of MHV-76 showed that despite quick clearance from lungs it established latency, though at a lower rate. Quite surprisingly, MHV-76 reactivated and replicated to high titres at remote intervals up to 27 months p.i., fulfilling the criterion of persistent infection, characterized by continuous or interrupted production of infectious virus [7] . In contrast, "true" non-productive latency means long term presence of MHV DNA with very limited transcription of latency associated genes, not resulting in virus replication.
Another 5´-end spontaneous deletion, though less extensive, was later described with MHV-72. This virus, originally isolated in the laboratory of the Chair of Microbiology and Virology, Faculty of Natural Science of CU in Bratislava, was studied in several laboratories. As described by Oda et al. [33] an approximately 7000 bp deletion was found at the 5´-end of the MHV-72 genome as confirmed by extensive PCR amplification studies (including 15 ORFs), Southern blot analysis and direct sequencing. The deletion in question encompassed the vtRNA sequences and the sequences encoding the M1, M2 and M3 genes. Biological studies in an independent laboratory confirmed the ability of MHV-72 to form tumors of histological appearance similar to that previously described [31] . Studies using SCID mice versus immunocompetent CB17 w.t. mice showed that the rate of tumor formation under conditions of immunosuppression increased three-fold. As already described, FK-506 treatment increased the rate of tumor formation two-fold [32] . In contrast to the highly passaged MHV-72 virus, its low passaged clone h. Recently, amplification of the MHV-Šum DNA using primers for the M1, M2, M3 and M4 genes showed the that it lacks approximately a 9.3 kb genomic region from the left end of the viral genome [52] . The PCR analyses performed with the MHV-Šum isolate revealed the absence of M1, M2 and M3 sequences, while the ORF4 sequences were in part amplified. When mapping more precisely the 3´-end of the deletion within the M4 ORF of the MHV-Šum genome, PCR amplification of ORF4-M4 region suggested that the deletion extended beyond the M3 ORF, thus encompassing a portion of the M4 gene. Since the latter result was not confirmed by Southern blot or direct sequencing, the precise length of the MHV-Šum 5´-end deletion must still be determined. Most unclear is the deletion within the MHV-60 genome (Table 2 ).
Characterisation of unique (MuHV

4-specific) genes located within the 5´-end of the genome
The M1/ORF1 is claimed to display homology to the poxvirus serin protease inhibitor serpin, SPI-2 [46] . Nevertheless, the presence of M1 protein was not shown to hamper the development of cytotoxic and NK cell responses nor to interfere with the induction of apoptosis, functions attributed to the family of serpin poteins [53] . The possible function of MuHV 4 M1 was investigated by inserting a LacZ casette into M1 ORF in order to create a recombinant M1.LacZ virus. The M1.LacZ recombinant exhibited decreased virus titres in the spleen of immunocompetent as well as immunodeficient mice during acute stages p.i. Despite this, it established latent infection comparable to that of w.t. virus, indicating that the establishment of latency was not determined by the extent of acute virus replication. Finally, the M1 deficient virus showed an increased rate of reactivation [54] . Initially, based on its genomic position, the MHV-68 M2 was identified as a latency candidate gene [55] . Expression of M2 protein has been detected in splenocytes during latency and in peritoneal exudate cells (PECs) without detectable lytic-gene expression [56] . The M2 transcripts have been found in the spleen and lungs during the first month p.i. The latter study raised the question of whether M2 may be expressed during productive virus replication as well as during latency. During latency, M2 expression was shown to be restricted to spleen [57] . In addition, M2 was expressed in latently infected murine B cells of lymphoma line S11, which was derived from a tumor found in a persistently infected mouse. Liang et al. [58] described the cell type dependent localization pattern for MHV-68 M2 expression. In lymphocytes, this protein was seen in the cytoplasm and cell membranes, while in
Virus strain
The epithelial cells and fibroblasts it was detected solely within the nucleus. Mutational analysis indicated that M2 has positively charged internal amino acids. Purification of M2 showed that it interacts with the cellular p32 protein, which recruits the complex into the nucleus. M2 inhibits the IFN action triggered by its binding to IFN receptor and resulting in the activation of corresponding intracellular pathways. Nuclear M2 downregulates the expression of the signal transduction and transactivation (STAT) proteins 1 and 2, which mediate the transcription of IFN-reactive cellular proteins. In MHV-68 infected fibroblasts the M2 protein acts as an IFN antagonist, representing an immune evasion mechanism for the maintenance of latent infection (Table 3) .
The expression of the M2 gene was examined in B lymphocytes during acute infection as well as during latency in mice inoculated by the i.n. route [15] . While the proportion of M2-positive splenocytes was 311:1 (day 14 p.i), their proportion decreased sharply (by 47 fold) by day 21 p.i., to decrease even further (nearly 2400 fold) by day 153 p.i. It was shown that vaccination with M2 reduces the M2 protein load of latently infected B cells in the spleen at early intervals and abolished latency at late intervals p.i. [59] . The specific T/CD8 cell response appearing from day 14 p.i. was undetectable during long-term latency. Adoptive-transfer studies also demonstrated that the T/CD8 cells specific for M2 initially reduced, but did not limit the long-term load of that protein. The splenic lymphocytosis, which was found to be independent of M2 expression, could be separated from the establishment of latency [57] . Mutation of the M2 gene did not affect the ability of the virus to replicate in tissue culture, nor did it affect MHV-68 virulence. However, M2 was differentially required for acute replication in vivo, being indispensable for virus production in the spleen but not in the lungs [60] . The M2 mutant virus was defective in its ability to cause the transient sharp rise in latently infected cells normally seen in the spleen after w.t. MHV-68 infection, but showed no defect in productive replication within lungs. Following i.n. inoculation, the cells positive for the M2 mutant inefficiently reactivated from latency as compared to wild-type and marker rescue viruses. In contrast, after intraperitoneal inoculation of the M2 mutant virus, no significant defect was observed in latency establishment or reactivation. From these considerations it was concluded that M2 plays some role in the establishment of and reactivation from latency in the spleen soon after i.n. inoculation. However, M2 may be not be crucial for establishing splenic latency following intraperitoneal application. The significance of the latter finding is unclear, at least regarding to the ability of M2 to block IFN signaling.
The MHV M3 gene encodes a soluble chemokine binding protein, which potentially interferes with natural chemokines and their interactions with corresponding receptors [61, 62] . The 46K M3 polypeptide is secreted from MHV-infected cells. This protein is encoded by an early-late 1.4 kb mRNA that initiates at nt 7294 and terminates downstream at nt 6007 followed by a canonic polyA signal 9 bp apart. Recently, the M3 protein has been shown to be capable of binding a broad variety of chemokines and neutralizing the cellular responses to them in vitro [63] . In vivo it probably attenuates the immune response and assists in regulation of leukocyte recruitment that could lead to enhanced virus replication [64] . As recently shown, M3 is a secreted protein; its soluble form interacts with many residues of CCL2 chemokines, including monocyte chemotactic proteins (MCP) and macrophage inflammatory proteins (MIP), all of which are recognized by the cellular receptor CCR2. Interestingly, the interaction of M3 with CCL2 chemokines mimics their binding with the corresponding CCR2 receptor. M3 was also shown to interact with some CXC chemokines with relatively high affinities [65] . It also binds to many inflammatory and chemotactic proteins, like eotaxin, fractalkine, lymphotactine, RANTES, etc. M3 is an example of a soluble chemokine modulator acting as immune evasion tool. DNA vaccination of mice with an M3 expressing plasmid yielded partial protection lowering the infectious virus titre in the lungs of challenged animals [66] . The latter authors showed that M3 elicited a cytotoxic T cell response during acute infection, which persisted at later stages of latency. It Table 3 . Possible function of proteins encoded by the 5´-end of the MuHV 4 genome.
? = no anti-apoptotic function has been attributed to M1 protein
Comparison of pathogenic properties of the murid gammaherpesvirus (MuHV 4) strains: a role for immunomodulatory proteins encoded by the left (5'-)end of the genome may be suggested that M3 itself can act as an immune target for virus specific TCRs. Summing up, the 5'-end of the MHV genome encodes at least two immune evasion proteins, namely M2 (a blocker of IFN type I responsive genes), and M3 (a soluble chemokine inhibitor active during latency).
The function of the next MHV specific gene, designated M4, was long obscure. Recently, it has been followed by means of MHV-76inM4, a mutant with the M4 gene inserted. To understand why this MHV-76 construct was prepared, it should be mentioned that MHV-76 is a spontaneous deletion mutant lacking a 9.53 kb segment from the 5'-end of the genome ( Table 2 ). The missing DNA region encompasses the M1, M2, M3 and M4 ORFs as well as sequences coding for the vtRNA transcripts [42] . As described above, MHV-76 is more rapidly cleared from lungs as compared with the protoptype MHV-68 strain. Acute splenomegaly was found to be reduced following i.n. MHV-76 inoculation and, furthermore, long-term latency could be established at considerably lower frequency compared with the prototype strain. The MHV-76inM4 construct (with M4 reinserted) grew similarly in vitro as did the w.t. MHV-76. However, in MHV-76inM4 infected Balb/c mice, acute virus titres, especially in lungs, were higher than in animals inoculated with the w.t. virus (in which the virus was quickly cleared). At days 17 and 21 p.i., the persisting virus load of MHV-76inM4 -as detected by co-cultivation -was higher also in splenocytes. During acute infection, the M4 polypeptide of the prototype MHV-68 strain was expressed in lungs and within spleen. The M4 protein encoded by the MHV76inM4 construct was also expressed in the lungs during acute infection and within the spleen at day 21 p.i., but became undetectable at late latency intervals, i.e. from day 100 p.i. [67] . These data would indicate that M4 may have some role in the modulation of immune response. Nevertheless, the interpretation of the experiments with MHV-76inM4 is difficult due to the absence of the M2 and M3 gene products. To overcome this problem, two deletion mutants of MHV-68 were constructed, namely M4stop (a stop codon inserted at nt 8672 allowing expression of a 22 aa oligopeptide instead of the 393 aa full protein) and an independent deletion mutant lacking nt 8385-9155 (M4del). No differences in the acute phase virus titres within lungs were seen with all M4 negative MHV-68 mutants in comparison with the w.t. virus [68] . It should be noted in this context that at early intervals following i.n. inoculation (days 1-3) the MHV76inM4 construct grew to higher titres in lungs than the MHV-76 strain. It is possible that the MHV-76 strain lacking the M3 immune evasion protein replicates better in the presence of M4 protein, since the M3 negative virus cannot grow to high titres at the portal of entry [69] . The level of spleen virus load was similar with the M4 negative mutants and the w.t. virus at day 10 p.i., but later on a nearly 100 fold difference was found. At day 30 p.i., the M4stop virus was completely cleared. Considerably decreased levels of the M4stop virus DNA were found at the late p.i. intervals as detected by PCR (using M4-specific primers).
As shown by Evans et al. [70] , M4 is a secreted glycoprotein which might bind to receptors of cells involved in the immune response. Alternatively, the M4 glycoprotein could interfere with the action of chemokines and/or cytokines. While M3 as well as M2 proteins are immune evasion tools used to increase the rate of virus replication, M4 might delay virus clearance and/or stimulate proliferation of cells involved in immune response. Therefore, the latent load of the M4 negative strains is consistently lower than of the w.t. virus. This was evident in the case of the M4 disruption mutant, which was most severely limited in establishment of latency. Nevertheless, a minimum copy number of the MuHV 4 genome is required for initiation of false positive signaling involved in cellular proliferation [71] . IFN-g deficient mice developed very severe splenic, mediastinal lymph node and lung pathologies when infected with the MHV-68 strain, but not when infected with mutants showing artificial left end deletions of varying lengths. It became clear from these studies, that the severe pathology seen in IFN-g deficient mice infected with MHV-68 containing the complete 5-end sequence could not be explained by the presence of any presently defined genes in the given region.
The survey of known virus-specific proteins encoded by the 5'-end of the MuHV 4 genome is given in Table 3 . It should be noted in this context that the left hand (5'-end) region of the MuHV 4 genome might encode at least two additional genes that remain uncharacterized [72] .
Conclusions and perspectives
The growth of MuHV-4 strains (or isolates), which bear deletions in the 5´-end region of their genome, was not hampered in cell cultures. All MHV viruses were able to infect Balb/c mice. The deletions in question had varying impact on the virus load at early stages p.i. and at least minimal latency could be established even when the 5'-end of the genome was missing. Paradoxically, the rate and extent of reactivation (despite of the low number of cells carrying the latent virus), was the highest with MHV-76, which reactivated easily at remote p.i. intervals and grew to high titers following reactivation. On the other hand, the rate of spontaneously occurring tumors was the highest in mice infected with MHV-60, which regularly entered non-productive virus latency rather than productive persistence. In connection with this, one may hypothesize the following: (A) M2 and M3 immune evasion polypeptides increase the extent of virus replication during the acute stage p.i., help to disseminate the virus via blood stream and increase its likelihood of establishing latency. The M3 polypeptide, which interacts with several cytokines, may be useful for virus replication in the spleen and other lymphatic tissues. Even in the absence of M2/M3 polypeptides, the immune evasion functions may not be fully abolished due to expression of the MK3 polypeptide and/or related proteins. (B) The MHV-76 virus was quickly eliminated from lungs, but grew better following reactivation of latency, since the missing M4 glycoprotein could not signal the onset of virus production. Thus, at remote intervals persistent production of infectious virus occurred due to the absence of M4 signaling.
The 24-27 month follow-up of Balb/c mice, which had been infected with MHV-76, showed neither tumors nor splenomegaly at late intervals p.i. The continuous (persistent) virus replication at latency sites does not favor transformation. Alternatively, UV light irradiated oncogenic DNA viruses had been frequently used to demonstrate their potential capacity to transform cells in vitro. This approach aimed to avoid productive virus replication and concomitant apoptosis. It is known that oncogenic DNA viruses encode non-structural polypeptides which bind cellular anti-onc proteins such as p53 and Rb. Disruption of the regulatory events controlling cell division is the consequence of interaction of "oncogenic" viral proteins with the cellular regulatory proteins [73] . Such interactions regarding MuHV 4 (and related gammaherpesviruses) have been described elsewhere [74] . We hypothesize that the MuHV-4 coded oncoproteins (such as v-Cyclin/ORF72, LANA/ORF73) in combination with those blocking apoptosis (v-bcl-2/ M11) could cause host cell immortalization and/or transformation especially in the absence of productive virus growth. However, it is not known whether the MuHV 4 DNA is present in all tumors developing in the virus-exposed animals. Therefore, the possibility of a complex long term immune stimulation following low rate persistence or abortive virus replication cannot be excluded as an additional cause of slowly progressing lymphoproliferation.
